Compare ENOV & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENOV | ETV |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2008 | N/A |
| Metric | ENOV | ETV |
|---|---|---|
| Price | $21.23 | $14.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $48.13 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 252.5K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,233,266,000.00 | N/A |
| Revenue This Year | $9.22 | N/A |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.57 | N/A |
| 52 Week Low | $21.90 | $11.05 |
| 52 Week High | $49.38 | $13.50 |
| Indicator | ENOV | ETV |
|---|---|---|
| Relative Strength Index (RSI) | 27.64 | 57.24 |
| Support Level | $22.50 | $14.13 |
| Resistance Level | $24.46 | $14.48 |
| Average True Range (ATR) | 1.28 | 0.12 |
| MACD | -0.37 | 0.01 |
| Stochastic Oscillator | 0.46 | 86.27 |
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.